title: Estimation of the contribution of private providers in tuberculosis case notification and treatment outcome in Pakistan.
abstract: To improve involvement of the private sector in the national tuberculosis (TB) programme in Pakistan various public-private mix projects were set up between 2004 and 2009. A retrospective analysis of data was made to study 6 different public-private mix models for TB control in Pakistan and estimate the contribution of the various private providers to TB case notification and treatment outcome. The number of TB cases notified through the private sector increased significantly from 77 cases in 2004 to 37,656 in 2009. Among the models, the nongovernmental organization model made the greatest contribution to case notification (58.3%), followed by the hospital-based model (18.9%). Treatment success was highest for the district-led model (94.1%) and lowest for the hospital-based model (74.2%). The private sector made an important contribution to the national data through the various public-private mix projects. Issues of sustainability and the lack of treatment supporters are discussed as reasons for lack of success of some projects.
authors.affiliation: National TB Control Programme, Islamabad, Pakistan. doctorahmad75@gmail.com
authors.forename: A A
authors.initials: AA
authors.lastname: Chughtai
authors.forename: E
authors.initials: E
authors.lastname: Qadeer
authors.forename: W
authors.initials: W
authors.lastname: Khan
authors.forename: H
authors.initials: H
authors.lastname: Hadi
authors.forename: I A
authors.initials: IA
authors.lastname: Memon
mesh_terms: D023801:Directly Observed Therapy / Q000379:methods* / Q000592:standards; D018563:Disease Notification / Q000706:statistics & numerical data; D006801:Humans; D009313:National Health Programs; D010154:Pakistan / Q000453:epidemiology; D017149:Private Sector; D055818:Public-Private Sector Partnerships; D012189:Retrospective Studies; D016896:Treatment Outcome; D014376:Tuberculosis / Q000453:epidemiology / Q000517:prevention & control / Q000628:therapy*